Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2020 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab.
Sciascia S, Rilat MLA, Fenoglio R, Foddai SG, Radin M, Cecchi I, Cinnirella G, Crosasso P, Guidetti MG, Barinotti A, Baldovino S, Menegatti E, Roccatello D. Sciascia S, et al. Among authors: crosasso p. Clin Kidney J. 2023 May 15;16(9):1465-1468. doi: 10.1093/ckj/sfad111. eCollection 2023 Sep. Clin Kidney J. 2023. PMID: 37664578 Free PMC article.
Skin antisepsis with chlorhexidine versus iodine for the prevention of surgical site infection: A systematic review and meta-analysis.
Privitera GP, Costa AL, Brusaferro S, Chirletti P, Crosasso P, Massimetti G, Nespoli A, Petrosillo N, Pittiruti M, Scoppettuolo G, Tumietto F, Viale P. Privitera GP, et al. Among authors: crosasso p. Am J Infect Control. 2017 Feb 1;45(2):180-189. doi: 10.1016/j.ajic.2016.09.017. Epub 2016 Nov 9. Am J Infect Control. 2017. PMID: 27838164 Review.
Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App.
Radin M, Arbrile M, Cecchi I, Di Nunzio P, Buccarano N, Di Gregorio F, Milone V, Osella S, Crosasso P, Favuzzi MD, Barinotti A, Baldovino S, Menegatti E, Rossi D, Sciascia S, Roccatello D. Radin M, et al. Among authors: crosasso p. Int J Environ Res Public Health. 2022 Apr 28;19(9):5379. doi: 10.3390/ijerph19095379. Int J Environ Res Public Health. 2022. PMID: 35564772 Free PMC article.
Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTORApp-A Usability Study.
Sciascia S, Radin M, Cecchi I, Di Nunzio P, Buccarano N, Di Gregorio F, Valeria M, Osella S, Crosasso P, Favuzzi MD, Rubini E, Foddai SG, Baldovino S, Roccatello D, Rossi D. Sciascia S, et al. Among authors: crosasso p. Int J Environ Res Public Health. 2020 May 15;17(10):3469. doi: 10.3390/ijerph17103469. Int J Environ Res Public Health. 2020. PMID: 32429245 Free PMC article.
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19.
Sciascia S, Aprà F, Baffa A, Baldovino S, Boaro D, Boero R, Bonora S, Calcagno A, Cecchi I, Cinnirella G, Converso M, Cozzi M, Crosasso P, De Iaco F, Di Perri G, Eandi M, Fenoglio R, Giusti M, Imperiale D, Imperiale G, Livigni S, Manno E, Massara C, Milone V, Natale G, Navarra M, Oddone V, Osella S, Piccioni P, Radin M, Roccatello D, Rossi D. Sciascia S, et al. Among authors: crosasso p. Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1. Clin Exp Rheumatol. 2020. PMID: 32359035 Free article.